A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
Male
0301 basic medicine
Vitamines
dietary biomarkers
Medicine (miscellaneous)
dietary biomarker
HOMOCYSTEINE
PLASMA PYRIDOXAL 5'-PHOSPHATE
vitamin B6
09 Engineering
SERUM
DIETARY-INTAKE
Neoplasms
Medicine and Health Sciences
AMINO-ACIDS
Càncer
ONE-CARBON METABOLISM
11 Medical and Health Sciences
Cancer
2. Zero hunger
Nutrition and Dietetics
SOLUBLE VITAMINS
Factors de risc en les malalties
Biochemical markers
Estudios de Casos y Controles
Vitamins
Middle Aged
Neoplasias
3. Good health
Europe
MICROBIOLOGICAL ASSAY
Original Research Communications
Marcadors bioquímics
Female
Vitamin B 6 Deficiency
Life Sciences & Biomedicine
kynurenine pathway
Risk factors in diseases
Vitamin B 6/blood
BIOMARKERS
610
Nutritional Status
PLP
03 medical and health sciences
Humans
transsulfuration pathway
Aged
Cancer och onkologi
Science & Technology
Nutrition & Dietetics
Vitamin B 6
Cancer and Oncology
Case-Control Studies
Linear Models
B-VITAMINS
Vitamina B 6
Neoplasms/epidemiology
DOI:
10.1093/ajcn/nqab045
Publication Date:
2021-02-23T20:16:06Z
AUTHORS (36)
ABSTRACT
Vitamin B6 insufficiency has been linked to increased risk of cancer and other chronic diseases. The circulating concentration pyridoxal 5′-phosphate (PLP) is a commonly used measure vitamin status. Ratios substrates indicating PLP coenzymatic function metabolism may be useful complementary measures further explore the role in health. We explored sensitivity 5 outcomes, namely concentration, homocysteine:cysteine (Hcy:Cys), cystathionine:cysteine (Cysta:Cys), 3´-hydroxykynurenine ratio (HKr), 4-pyridoxic acid (PAr) intake as well personal lifestyle characteristics. Dietary biomarker data were collected from participants 3 nested case-control studies within European Prospective Investigation into Cancer Nutrition (EPIC). Bayesian regression models assessed associations outcomes with covariates. Analogous examined relations Hcy:Cys, Cysta:Cys, HKr PLP. In total, 4608 included analyses. was most strongly associated PLP, moderately HKr, not PAr (fold change marker given doubling intake: 1.60 [95% credible interval (CrI): 1.50, 1.71]; Hcy:Cys 0.87 CrI: 0.84, 0.90]; Cysta:Cys 0.89 0.94]; 0.88 0.85, 0.91]; 1.00 0.95, 1.05]). sensitive age, least BMI alcohol intake. Sex menopause status all markers. found that different markers, capturing aspects B6–related biological processes, varied their predictors.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (45)
CITATIONS (8)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....